Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jason Glanz to Analgesics, Opioid

This is a "connection" page, showing publications Jason Glanz has written about Analgesics, Opioid.

 
Connection Strength
  
 
 
3.413
  
  1. McClure DL, Binswanger IA, Narwaney KJ, Ford MA, Nguyen AP, Rinehart DJ, Glanz JM. Patterns of long-term opioid therapy with prior nonpharmacologic pain management utilization. Sci Rep. 2025 Aug 29; 15(1):31924.
    View in: PubMed
    Score: 0.494
  2. Binswanger IA, Shetterly SM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Nguyen AP, Glanz JM. Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022 10 03; 5(10):e2234671.
    View in: PubMed
    Score: 0.404
  3. Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S. Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019 04 05; 2(4):e192613.
    View in: PubMed
    Score: 0.317
  4. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
    View in: PubMed
    Score: 0.292
  5. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015 Dec; 30(12):1837-44.
    View in: PubMed
    Score: 0.251
  6. Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3.
    View in: PubMed
    Score: 0.238
  7. Guan X, Jurecka C, Padmanabhan P, Yamkovoy K, Christine PJ, Binswanger IA, Glanz JM, Kline DM, Barocas JA. Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in Colorado. Int J Drug Policy. 2025 12; 146:105037.
    View in: PubMed
    Score: 0.125
  8. Jurecka C, Adams J, Padmanabhan P, Glanz J, Christine P, Guan X, Kline D, Binswanger I, Barocas J. Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths. JAMA Health Forum. 2025 Aug 01; 6(8):e252654.
    View in: PubMed
    Score: 0.123
  9. Pytell JD, Narwaney KJ, Nguyen AP, Glanz JM, Binswanger IA. New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy. J Addict Med. 2025 May-Jun 01; 19(3):290-297.
    View in: PubMed
    Score: 0.117
  10. Xu S, Narwaney KJ, Nguyen AP, Binswanger IA, McClure DL, Glanz JM. An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data. Pharmacoepidemiol Drug Saf. 2024 01; 33(1):e5708.
    View in: PubMed
    Score: 0.108
  11. Glanz JM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Ford MA, Nguyen AP, Binswanger IA. Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Subst Abus. 2023 07; 44(3):209-219.
    View in: PubMed
    Score: 0.108
  12. Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 01; 118(1):97-107.
    View in: PubMed
    Score: 0.100
  13. Binswanger IA, Rinehart D, Mueller SR, Narwaney KJ, Stowell M, Wagner N, Xu S, Hanratty R, Blum J, McVaney K, Glanz JM. Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial. J Gen Intern Med. 2022 08; 37(11):2624-2633.
    View in: PubMed
    Score: 0.096
  14. Shoup JA, Mueller SR, Binswanger IA, Williams AV, Strang J, Glanz JM. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS. Pain Med. 2020 10 01; 21(10):2244-2252.
    View in: PubMed
    Score: 0.088
  15. Binswanger IA, Glanz JM, Faul M, Shoup JA, Quintana LM, Lyden J, Xu S, Narwaney KJ. The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug Alcohol Depend. 2020 12 01; 217:108248.
    View in: PubMed
    Score: 0.087
  16. Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020 03 02; 3(3):e201018.
    View in: PubMed
    Score: 0.084
  17. Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019; 40(1):71-79.
    View in: PubMed
    Score: 0.079
  18. Binswanger IA, Glanz JM. Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980.
    View in: PubMed
    Score: 0.076
  19. Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain. J Gen Intern Med. 2017 Mar; 32(3):277-283.
    View in: PubMed
    Score: 0.067
  20. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53.
    View in: PubMed
    Score: 0.060
  21. Nguyen AP, Glanz JM, Narwaney KJ, Zeng C, Wright L, Fairbairn LM, Binswanger IA. Update of a Multivariable Opioid Overdose Risk Prediction Model to Enhance Clinical Care for Long-term Opioid Therapy Patients. J Gen Intern Med. 2023 09; 38(12):2678-2685.
    View in: PubMed
    Score: 0.026
  22. Lyden JR, Xu S, Narwaney KJ, Glanz JM, Binswanger IA. Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis. J Gen Intern Med. 2023 08; 38(11):2560-2567.
    View in: PubMed
    Score: 0.026
  23. Nguyen AP, Glanz JM, Shoup JA, Campbell CI, Clarke CL, Ford MA, Binswanger IA. Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System. J Gen Intern Med. 2022 08; 37(11):2882-2884.
    View in: PubMed
    Score: 0.024
  24. Mueller SR, Glanz JM, Nguyen AP, Stowell M, Koester S, Rinehart DJ, Binswanger IA. Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. Int J Drug Policy. 2021 06; 92:103077.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)